4 results about "Artificial abortion" patented technology

This invention discloses the application of ethinylestradiol and drospirenone in the preparation of drugs for treating post-traumatic stress disorder (PTSD). Ethinylestradiol, as an estrogen receptor agonist, regulates the hypothalamic-pituitary-gonadal axis and is used to treat female hypogonadism, menopausal syndrome, and advanced breast cancer, often in combination with progestins as oral contraceptives. The use of drospirenone and ethinylestradiol tablets (II) after induced abortion can shorten vaginal bleeding time, promote endometrial repair, and reduce the incidence of postoperative complications and repeat miscarriages. This invention has found that ethinylestradiol and drospirenone can reverse the abnormal decrease in hormones and neurosteroids caused by PTSD after spontaneous abortion, particularly the abnormal decrease in serotonin and tetrahydroprogesterone.

The application provides a pharmaceutical composition for treating gynecological inflammation and a preparation method thereof, and belongs to the technical field of medicines. After being subjected to water extraction and alcohol extraction, Sophora flavescens, Phellodendri chinensis, Forsythia suspensa and Ligustrum lucidum are used to obtain traditional Chinese medicine water extracts and traditional Chinese medicine alcohol extracts; the traditional Chinese medicine water extracts are reacted with silver salt and copper salt to obtain traditional Chinese medicine water extract-metal ion complex; the traditional Chinese medicine water extract-metal ion complex is mixed with the traditional Chinese medicine alcohol extracts, sodium taurodeoxycholate, laurocapram and berberine to prepare nanometer drug delivery micelles; and the nanometer drug delivery micelles are added into a hydrogel of chitosan, poloxamer P407 and poloxamer P188 to prepare the pharmaceutical composition for treating gynecological inflammation. The prepared composition has excellent treatment effect and low toxicity, thereby reducing the cost and improving the treatment effect of gynecological diseases such as chronic pelvic inflammatory disease, chronic cervicitis, vaginitis and artificial abortion complications, and has a wide application prospect.

The invention discloses an intelligent negative pressure monitoring system for a negative pressure induced abortion operation, which is characterized in that an electric abortion aspirator is connected with a pressure sensor through a negative pressure induction manifold, the electric abortion aspirator is connected with a negative pressure aspiration tube through a pipeline, the negative pressure aspiration tube is provided with a handheld handle, and a miniature gyroscope is arranged in the handheld handle; an intelligent monitoring system is arranged in the monitoring computer, the monitoring computer comprises a monitoring simulation module and an intelligent control early warning module, the monitoring simulation module obtains and processes control data based on the micro gyroscope to carry out animation simulation display, and the intelligent control early warning module carries out real-time monitoring and early warning prompt on the intraoperative total negative pressure impulse and the operation duration based on the pressure sensor; according to the negative pressure suction tube, the sliding frequency of the negative pressure suction tube in the uterine cavity and the operation time can be reduced to the maximum extent, meanwhile, the uterine cavity is completely covered as much as possible, pregnancy tissue in the uterine cavity is sucked out through stable negative pressure, and the situation that due to repeated operation of the negative pressure suction tube in the uterine cavity, the intima of the uterine cavity is damaged, and the risk of female fertility damage is increased is avoided.

The invention provides application of blood nourishing oral liquid combined with drospirenone ethinylestradiol in clinical symptoms and endometrial receptivity after an induced abortion operation, and belongs to the technical field of biological medicine. According to the application of the blood nourishing oral liquid and the drospirenone ethinylestradiol in preparation of the medicine for improving the clinical symptoms after the induced abortion operation, the result of the embodiment shows that compared with a drospirenone ethinylestradiol single administration group, the combined administration group has the advantages that the vaginal bleeding duration is shorter, the vaginal bleeding amount is smaller, the abdominal pain degree is lower, and the clinical symptoms after the induced abortion operation can be improved. The dominant follicle size, the endometrial thickness, the endometrial volume, the type A endometrial rate, the type III endometrial and the ratio of the endometrial-muscular layer binding band are all higher than those of a control group, and the aneurysm hemodynamic indexes are all lower than those of a single administration group. Therefore, the blood-nourishing oral liquid combined with drospirenone ethinylestradiol can effectively improve postoperative clinical symptoms of patients, promote follicle development and improve endometrial receptivity.